When the Teen Recipient Refuses Medications
A 16-year-old girl is 8 months post liver transplant for biliary atresia. She has recently begun refusing tacrolimus, saying it makes her 'puffy and ugly,' and has missed doses on roughly half of days for 3 weeks. Her tacrolimus level is 2.1 ng/mL (target 5-8). Liver enzymes are rising (ALT 88, up from 30). She is otherwise well. Her parents are divorced and disagree: her mother wants stricter control; her father says 'it's her body.' She is mature for her age, understands the consequences, and is tearful but firm. She asks the team to stop 'nagging' her.
1. How should the team balance adolescent autonomy against the medical necessity of immunosuppression?
Read the worked answer
Frame it as shared decision-making, not a power struggle.
- Clinical reality: Subtherapeutic levels and rising ALT signal early rejection risk. This is time-sensitive but not yet emergent.
- Her stated concern is real: Steroid/corticosteroid-related puffiness and body-image distress are legitimate and often modifiable - discuss steroid-sparing strategies, timing, and the fact that tacrolimus itself is not the main cause of puffiness. Address appearance concerns seriously rather than dismissing them.
- Autonomy: A mature minor's preferences deserve weight, but refusal here risks graft loss. Autonomy is honored by giving her genuine choices (formulation, timing, who administers, what support she wants), not by abandoning treatment.
- Include both parents in a unified plan to avoid triangulation; the father's 'her body' stance can be engaged by asking what he wants for her long-term health.
Action: Urgent level recheck, adherence support (pill boxes, reminders, pharmacy sync), adolescent psychology/peer support referral, and a written agreement. Escalate to ethics/child-protection consultation only if refusal continues and graft is threatened.
2. If she continues to refuse and her liver enzymes worsen, what is the appropriate escalation pathway, and what should be avoided?
Read the worked answer
Escalation, in order:
- Intensified multidisciplinary meeting (hepatology, adolescent medicine, psychology, social work, both parents, patient).
- Consider a time-limited trial of an alternative regimen or supervised administration.
- Ethics consultation to clarify decision-making standards for a mature minor.
- If imminent graft-threatening rejection and refusal persist, involve child protective/legal processes per institutional policy - a last resort.
Avoid:
- Covert administration or deception.
- Threatening or shaming her.
- Unilaterally stopping immunosuppression to 'respect autonomy' when the consequence is predictable graft loss.
- Letting parental disagreement stall action.
Principle: The goal is to preserve both her graft and her trust; heavy-handed control often worsens nonadherence in adolescents.